Answers are grounded in this paper and cite their sources.
at industrial levels by a variety of companies-describing how the industry has leveraged its key features, from products for the ingredients of meat-free burgers (e.g., IMPOSSIBLE™ FOODS, USA) to diabetes therapeutics (e.g., Biocon, India)-is provided. Furthermore, active patents and the typical workflow for industrial protein production with this strain are reported.
No takes yet. Share an insight, caveat, or question.
Barone et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: